#cardiacintervention

Dr. Aritra Konar is a skilled Interventional Cardiologist known for his dedication to modern, patient-focused heart care. With deep expertise in diagnosing and treating complex cardiovascular conditions, he plays an important role in helping patients recover faster and live healthier lives.

Dr. Konar specializes in advanced procedures such as coronary angiography and angioplasty, which help restore proper blood flow to the heart. By using minimally invasive techniques, he ensures reduced recovery time, less discomfort, and improved treatment outcomes for his patients.

He strongly believes that effective cardiac care involves not only medical procedures but also patient education and preventive guidance. Dr. Konar takes time to understand each patient’s condition and provides personalized treatment plans along with lifestyle recommendations to support long-term heart health.

His commitment to precision, innovation, and compassionate care has earned him the trust of many patients. Through his expertise and continuous efforts, Dr. Aritra Konar continues to contribute significantly to improving modern cardiac treatment and patient well-being. Visit us: https://draritrakonar.com/

Track 24: Biomarkers in Cardiology

5th International Heart Health and Cardiac Surgery Conference & Exhibition

The field of cardiology is undergoing a remarkable transformation driven by advances in molecular science, precision medicine, and diagnostic innovation. Among the most impactful developments is the growing role of biomarkers in cardiology, which are redefining how cardiovascular diseases are detected, monitored, and treated. Recognizing this critical evolution, the 5th International Heart Health and Cardiac Surgery Conference & Exhibition proudly presents Track 24: Biomarkers in Cardiology, a dedicated scientific platform for cutting-edge research, clinical applications, and translational breakthroughs.

Why Biomarkers Matter in Cardiology

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide. Early diagnosis, risk stratification, and personalized treatment strategies are essential to improving patient outcomes. Biomarkers—measurable biological indicators found in blood, tissues, or imaging—play a pivotal role in achieving these goals.

From cardiac troponins and natriuretic peptides to emerging genomic, proteomic, and metabolomics marker, biomarkers enable clinicians to:

Detect cardiovascular diseases at earlier stages

Predict disease progression and patient risk

Guide clinical decision-making

Monitor therapeutic response

Improve long-term prognosis

About Track 24: Biomarkers in Cardiology

Track 24 is designed to bring together cardiologists, cardiac surgeons, clinical researchers, laboratory specialists, molecular biologists, and healthcare innovators to explore the latest advancements in cardiovascular biomarkers. This track emphasizes both research excellence and real-world clinical integration, bridging the gap between laboratory discoveries and bedside practice.

Key Scientific Themes and Topics

This track will cover a wide range of contemporary and emerging topics, including but not limited to:

Established and novel cardiac biomarkers in ischemic heart disease

Biomarkers for heart failure diagnosis, prognosis, and management

Inflammatory and metabolic biomarkers in cardiovascular risk assessment

Genetic and epigenetic biomarkers in inherited cardiac disorders

Biomarkers in acute coronary syndromes and myocardial injury

Role of biomarkers in valvular heart disease and cardiomyopathies

Biomarkers guiding interventional and surgical cardiac procedures

Artificial intelligence and machine learning in biomarker discovery

Personalized and precision cardiology using biomarker-driven strategies

Clinical and Research Benefits for Participants

Attending this track offers significant value for both clinicians and researchers:

Enhanced Clinical Decision-Making: Learn how to integrate biomarkers into daily cardiology practice for improved diagnostic accuracy.

Early Disease Detection: Understand how emerging biomarkers can identify cardiovascular risk before symptoms appear.

Personalized Patient Care: Explore precision medicine approaches tailored to individual biomarker profiles.

Research Advancement: Gain insights into ongoing trials, translational research, and future directions in biomarker science.

Global Collaboration: Network with international experts and institutions shaping the future of cardiovascular diagnostics.

CME/CPD Accreditation Benefits

The 5th International Heart Health and Cardiac Surgery Conference & Exhibition is CME/CPD-accredited, ensuring that participants receive recognized educational credits for their professional development.

By attending Track 24, participants can:

Earn Continuing Medical Education (CME) and Continuing Professional Development (CPD) credits

Stay compliant with professional licensing and regulatory requirements

Demonstrate commitment to lifelong learning and clinical excellence

Enhance academic and professional credentials

The scientific sessions are carefully curated to meet international CME/CPD standards, combining evidence-based education with practical clinical relevance.

Who Should Attend This Track

This track is ideal for:

Cardiologists and cardiac surgeons

Internal medicine and emergency physicians

Clinical researchers and scientists

Laboratory and diagnostic professionals

Academicians and postgraduate trainees

Healthcare policymakers and industry experts

Call for Speakers, Abstracts, and Delegates

The Organizing Committee warmly invites speakers, researchers, poster presenters, and delegates to actively participate in Track 24. Share your research, clinical experiences, and innovative ideas with a global audience and contribute to shaping the future of cardiovascular medicine.

🔗 Learn more and register here: https://heart-health-and-surgery.utilitarianconferences.com/

Conclusion